Your English writing platform
Discover LudwigSuggestions(1)
Exact(10)
This orally active compound is now being evaluated for phase I trials at Nereus Pharmaceuticals for the treatment of refractory multiple myeloma.
This retrospective series reviews the outcome of 70 MBC patients who have participated in 30 phase I trials at the Royal Marsden Hospital from 2002 to 2009.
We performed this retrospective analysis in all patients who took part in phase I trials at the Drug Development Unit, Royal Marsden Hospital, over an 18-month period, from January 2005 to June 2006.
Although these data from a retrospective analysis of breast cancer patients treated in phase I trials at a single institution can only be interpreted in an exploratory manner, some interesting points can be highlighted.
We analysed the outcome of 212 consecutive patients who were treated from January 2005 to June 2006 in 29 phase I trials at the Drug Development Unit, Royal Marsden Hospital, Sutton, UK.
Lung cancer patients appeared to be eligible for phase I trials at initial consultation visits, but many were recommended other treatments first, or had rapid deterioration after initially being eligible.
Similar(50)
We analysed consecutive patients included in Phase-I trials at the Royal Marsden Hospital from 5 January 2005 to 6 June 2006.
For example, SLV-I trials at the state level in Hawaii and the three-county level in Minnesota resulted in very high vaccination rates of 46%% [ 25] and 41%% [ 46], respectively; however these were not clinical trials, no control schools existed, and the papers did not report what percent of vaccinations were delivered in school versus in physician offices.
In an SLV-I trial at nineteen elementary schools in California, coverage varied by school, with 26.9 %-46.6%-46.6%hindreachn each school receiving at least one dose of influenza vaccine with a large impact due to SLV-I; however in this setting control schools had virtually zero vaccination rates [ 47].
The Bethesda woman is taking part in a phase I trial at the U.S. National Institutes of Health (NIH), one of several small studies getting under way in four countries to assess this vaccine's safety and the immune responses it triggers.
France's health ministry said that the six volunteers at the facility in Rennes, Brittany, had been in good health until taking the oral medication, which was manufactured by Portugal-based Biandlabeing being tested in a Phase I trial at the Biotrial clinic in the northwestern French city.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com